Literature DB >> 14717607

Role of a conserved membrane-embedded acidic residue in the multidrug transporter MdfA.

Julia Adler1, Oded Lewinson, Eitan Bibi.   

Abstract

According to the current topology model of the Escherichia coli multidrug transporter MdfA, it contains a membrane-embedded negatively charged residue, Glu26, which was shown to play an important role in substrate recognition. To further elucidate the role of this substrate recognition determinant, various Glu26 replacements were characterized. Surprisingly, studies with neutral MdfA substrates showed that, unlike many enzymatic systems where the size and chemical properties of binding site residues are relatively defined, MdfA tolerates a variety of changes at position 26, including size, hydrophobicity, and charge. Moreover, although efficient transport of positively charged substrates requires a negative charge at position 26 (Glu or Asp), neutralization of this charge does not always abrogate the interaction of MdfA with cationic drugs, thus demonstrating that the negative charge does not play an essential role in the multidrug transport mechanism. Collectively, these results suggest a link between the broad substrate specificity profile of multidrug transporters and the structural and chemical promiscuity at their substrate recognition pockets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14717607     DOI: 10.1021/bi035485t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop.

Authors:  Thomas Eicher; Hi-jea Cha; Markus A Seeger; Lorenz Brandstätter; Jasmin El-Delik; Jürgen A Bohnert; Winfried V Kern; François Verrey; Markus G Grütter; Kay Diederichs; Klaas M Pos
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  No single irreplaceable acidic residues in the Escherichia coli secondary multidrug transporter MdfA.

Authors:  Nadejda Sigal; Shahar Molshanski-Mor; Eitan Bibi
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

3.  Transmembrane helix 12 of the Staphylococcus aureus multidrug transporter QacA lines the bivalent cationic drug binding pocket.

Authors:  Karl A Hassan; Ronald A Skurray; Melissa H Brown
Journal:  J Bacteriol       Date:  2007-10-19       Impact factor: 3.490

4.  The secondary multidrug/proton antiporter MdfA tolerates displacements of an essential negatively charged side chain.

Authors:  Nadejda Sigal; Nir Fluman; Shira Siemion; Eitan Bibi
Journal:  J Biol Chem       Date:  2009-01-07       Impact factor: 5.157

5.  A promiscuous conformational switch in the secondary multidrug transporter MdfA.

Authors:  Nir Fluman; Devora Cohen-Karni; Tali Weiss; Eitan Bibi
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

Review 6.  Interplay between the electrostatic membrane potential and conformational changes in membrane proteins.

Authors:  Xuejun C Zhang; Hang Li
Journal:  Protein Sci       Date:  2019-01-10       Impact factor: 6.725

7.  Manipulating the drug/proton antiport stoichiometry of the secondary multidrug transporter MdfA.

Authors:  Osnat Tirosh; Nadejda Sigal; Amir Gelman; Nadav Sahar; Nir Fluman; Shira Siemion; Eitan Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

8.  The Multidrug Transporter MdfA Deviates from the Canonical Model of Alternating Access of MFS Transporters.

Authors:  Eliane H Yardeni; Smriti Mishra; Richard A Stein; Eitan Bibi; Hassane S Mchaourab
Journal:  J Mol Biol       Date:  2020-08-26       Impact factor: 5.469

9.  Dissection of mechanistic principles of a secondary multidrug efflux protein.

Authors:  Nir Fluman; Christopher M Ryan; Julian P Whitelegge; Eitan Bibi
Journal:  Mol Cell       Date:  2012-07-26       Impact factor: 17.970

10.  Membrane protein biogenesis in Ffh- or FtsY-depleted Escherichia coli.

Authors:  Ido Yosef; Elena S Bochkareva; Julia Adler; Eitan Bibi
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.